BioTechniques welcomes preprints

11 February 2020

Now authors submitting preprints to bioRxiv will have the option to submit their work directly to BioTechniques.

Authors of existing bioRxiv preprints can choose to submit their manuscript for consideration at BioTechniques through the Direct Transfer program. This means that authors submitting preprints to bioRxiv will have the option to transfer their work straight to us, by transmitting their manuscript files and metadata directly from bioRxiv, saving re-entering author information during the submission process.

“We believe that preprints are a vital step towards a more open and transparent science — a step that brings great benefits for both the broad scientific community and individual authors.” commented Joseph Martin, Managing Editor.

To find out more about bioRxiv and the benefits of preprints, please see our recently published article here.

Additionally, if you have any questions regarding your bioRxiv preprint or BioTechniques submission, please get in touch with Managing Editor, Joseph Martin.

About BioTechniques

At BioTechniques we believe that the key to successful, reproducible science is the dissemination of information regarding new and innovative laboratory techniques to the people that need it most. The scope of BioTechniques comprises all laboratory methods and techniques related to the field of Life Sciences, and our aim is to unite the diverse members of this community with the ultimate goal of improving research and results by enabling collaboration and communication of techniques.

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies and products that deliver value-for-money and uncompromisingly high standards.

Don't forget to share this post!